Open Public Hearing

1
Open Public Hearing

• 1. Kim Porto

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
2
Open Public Hearing

• 2. Chris Coffin
• Pendley, Baudin Coffin, L.L.P.

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
3
Open Public Hearing

• 3. Ellen Hanson

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
4
Open Public Hearing

• 4. Julie Totten
• Families for Depression Awareness

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
5
Open Public Hearing

• 5. Suzanne Gonzalez

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
6
Open Public Hearing

• 6. John Mann
• New York State Psychiatric Institute of the
  Columbia University Medical Center

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
7
Open Public Hearing

• 8. Allen Jones
• Alliance for Human Research Protection

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
8
Open Public Hearing

• 9. Nick Korzie

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
9
Open Public Hearing

• 10. Christopher Kratochvil

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
10
Open Public Hearing

• 11. Darrel Reiger
• American Psychiatric Association

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
11
Open Public Hearing

• 12. Moira Dolan

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
12
Open Public Hearing

• 13. Deborrah Gruder

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
13
Open Public Hearing

• 15. Gwen Olsen

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
14
Open Public Hearing

• 16. Beverly Hatcher

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
15
Open Public Hearing

• 17. Ellen Liversidge
• Alliance for Human Research Protection

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
16
Open Public Hearing

• 18. Lisa van Syckel

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
17
Open Public Hearing

• 21. Charles Carpenter
• Paxil Progress, SSRI Crusaders, Prozac
  Awareness, The Effexor Activist

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
18
Open Public Hearing

• 22. Paula Clayton
• American Foundation for Suicide Prevention

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
19
Open Public Hearing

• 24. Diane Dorlester
• National Mental Health Association

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
20
Open Public Hearing

• 25. Lewis Kopolow

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
21
Open Public Hearing

• 26. Joseph Glenmullen

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
22
Open Public Hearing

• 27. Dan Reidenberg
• National Council for Suicide Prevention

23
Open Public Hearing

• 28. Karen Menzies /
• Debra Tucker

Psychopharmacologic Drugs Advisory Committee
December 13, 2006
24
Open Public Hearing

• 29. Michele Moore

25
Open Public Hearing

• 30. Tony Noll

26
Open Public Hearing

• 31. Mary Margaret Dick

27
Open Public Hearing

• 32. Donna Barnes
• National Organization for People of Color
  Against Suicide

28
Open Public Hearing

• 33. Sara Bostock

29
Open Public Hearing

• 34. Kim Witczak

30
Open Public Hearing

• 35. Joseph Weiner

31
Open Public Hearing

• 36. Angela Heck

32
Open Public Hearing

• 37. Sheila Matthews
• Able Child

33
Open Public Hearing

• 38. Robert Carolla
• National Alliance on
• Mental Illness

34
Open Public Hearing

• 40. Erin Crowley
• National Coalition for
• Drug Awareness

35
Open Public Hearing

• 41. Andy Vickery

36
Open Public Hearing

• 42. John R. Hayes
• Eli Lilly and Company

37
Open Public Hearing

• 43. Heidi Bryan
• Feeling Blue Suicide
• Prevention Council

38
Open Public Hearing

• 44. Mary Gardino
• Freedom from Fear
• Advocacy Group

39
Open Public Hearing

• 45. Donald J. Farber

40
Open Public Hearing

• 46. David Healy

41
Open Public Hearing

• 47. Lee Spiller
• Citizens Commission on Human Rights of Texas

42
Open Public Hearing

• 48. Carolyn Robinowitz

43
Open Public Hearing

• 49. Sheri Walton

44
Open Public Hearing

• 50. Jayne Richner

45
Open Public Hearing

• 51. Nancy Sharby

46
Open Public Hearing

• 52. Vera Sharav
• Alliance for Human
• Research Protection

47
Open Public Hearing

• 53. Kendrick Moxon
• MOXON KOBRIN

48
Open Public Hearing

• 54. David Shern
• Mental Health America

49
Open Public Hearing

• 55. Alison Malmon
• Active Minds, Inc.

50
Open Public Hearing

• 56. Ann Blake Tracy
• International Coalition
• for Drug Awareness

51
Open Public Hearing

• 57. Eric Caine
• Suicide Prevention Action Network USA

52
Open Public Hearing

• 58. Rosemary Dorsett

53
Open Public Hearing

• 59. Mary Ellen Winter

54
Open Public Hearing

• 60. Nada Stotland

55
Open Public Hearing

• 61. Roger Peele

56
Open Public Hearing

• 62. Eric Swan

57
Open Public Hearing

• 63. Dawn Jeronowitz

58
Open Public Hearing

• 64. Allen Routhier

59
Open Public Hearing

• 65. Anne Sheffield

60
Open Public Hearing

• 66. Laurie Yorke

61
Open Public Hearing

• 67. Hanna Stotland

62
Open Public Hearing

• 68. Charles F. Reynolds III
• American Association for Geriatric Psychiatry

63
Open Public Hearing

• 70. Peter Breggin
• The International Center for the Study of
  Psychiatry and Psychology

64
Open Public Hearing

• 71. Robert Gibbons

65
Open Public Hearing

• 72. Derek Braslow
• Pogust Braslow, LLC

66
Open Public Hearing

• 73. Carl Salzman
• American College of Neuropsychopharmacology

67
Open Public Hearing

• 74. Robert Valuck

68
Open Public Hearing

• 75. Steven Daviss

Psychopharmacologic Drugs Advisory Committee
December 13, 2006